Shayma El-Atawneh
Overview
Explore the profile of Shayma El-Atawneh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
14
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Atawneh S, Goldblum A
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337714
Repurposing utilizes existing drugs with known safety profiles and discovers new uses by combining experimental and computational approaches. The integration of computational methods has greatly advanced drug repurposing, offering a...
2.
El-Atawneh S, Goldblum A
J Chem Inf Model
. 2023 May;
63(11):3248-3262.
PMID: 37257045
G protein-coupled receptors (GPCRs) are targets of many drugs, of which ∼25% are indicated for central nervous system (CNS) disorders. Drug promiscuity affects their efficacy and safety profiles. Predicting the...
3.
El-Atawneh S, Goldblum A
Front Pharmacol
. 2022 Mar;
13:812745.
PMID: 35295337
In recent years, the cannabinoid type 2 receptor (CB2R) has become a major target for treating many disease conditions. The old therapeutic paradigm of "one disease-one target-one drug" is being...
4.
El-Atawneh S, Hirsch S, Hadar R, Tam J, Goldblum A
J Chem Inf Model
. 2020 Oct;
60(10):5282.
PMID: 33100016
No abstract available.
5.
El-Atawneh S, Hirsch S, Hadar R, Tam J, Goldblum A
J Chem Inf Model
. 2019 Aug;
59(9):3996-4006.
PMID: 31433190
Small molecules targeting peripheral CB1 receptors have therapeutic potential in a variety of disorders including obesity-related, hormonal, and metabolic abnormalities, while avoiding the psychoactive effects in the central nervous system....